Business Economy


AI-powered Cardiac Monitoring device' Kardi AI' to luanch in India

Hyderabad, Sep 18 (UNI) AI-powered long-term cardiac monitoring device 'Kardi Ai', developed by Czech HealthTech company , is set to be launched in India on September 26 and will be available on an annual subscription model costing around Rs 40,000, a company representative said on Friday.
Dr Ramana Jagarlamudi, Director–International Operations and Authorised Representative–India, Kardi Ai, and Dr Raghavendra Rao, Scientific Adviser and Co-Founder, Eurasia Medical Technologies LLP, announced the launch at a press conference here.
The India launch is being facilitated by Hyderabad-based Eurasia Medical Technologies LLP, the Indian arm of Kardi Ai, Dr Ramana said.
He said Kardi Ai has secured an MD-15 licence from the Government of India for import and sale in the country. The device is CE-marked under the European union medical-device regulatory framework and classified as an EU MDR Class IIa product.
Its manufacturing and quality processes are aligned with ISO 13485, the international quality-management standard for medical devices, he said.
The technology combines a wearable ECG chest strap, mobile connectivity and AI-supported ECG analysis to enable long-term monitoring of heart rhythm while patients continue their normal daily activities.
Dr Ramana said the device is designed to help identify intermittent heart-rhythm abnormalities that may not occur during a conventional ECG or even a 24-hour Holter examination.
While a conventional ECG provides a short snapshot of heart activity and a Holter records cardiac activity for a defined period, Kardi Ai provides a longer window of observation, he said.
The patient wears a lightweight ECG chest strap during everyday activities, with the recorded ECG data transmitted through a mobile platform. AI-supported analysis assists physicians in reviewing the data and identifying potential rhythm abnormalities, he said.
The technology is intended to support physicians and does not replace clinical diagnosis or medical decision-making, he said.
Dr Ramana also said the device had been patented and approved by the Government of India.
UNI KNR BM
More News

AI-powered Cardiac Monitoring device' Kardi AI' to luanch in India

18 Sep 2026 | 9:11 PM

Hyderabad, Sep 18 (UNI) AI-powered long-term cardiac monitoring device 'Kardi Ai', developed by Czech HealthTech company , is set to be launched in India on September 26 and will be available on an annual subscription model costing around Rs 40,000, a company representative said on Friday.

see more..

India's Cococnut exports surge 62 pc in one year to Rs 7,038 Cr : union Minister Chouhan

18 Sep 2026 | 7:50 PM

Hyderabad, Sept 18 (UNI) India's coconut exports rose 62 per cent in a year to Rs 7,038 crore from Rs 4,349 crore, union Agriculture and Farmers' Welfare Minister Shivraj Singh Chouhan said on Friday, highlighting the potential of the sector and calling for measures to further benefit farmers in southern states.

see more..

FTAs Open new opportunities for Indian farmers in Global Markets : union Minister Chouhan

18 Sep 2026 | 7:48 PM

Hyderabad, Sept 18 (UNI) Free Trade Agreements (FTAs) entered into by India are opening up new opportunities for farmers to access international markets, union Agriculture and Farmers' Welfare Minister Shivraj Singh Chouhan said on Friday, urging states to align agricultural production with global demand and quality standards.

see more..

NSE IPO gets strong response; Issue to be fully subscribed by End of Day : NSE CBDO

18 Sep 2026 | 7:20 PM

Hyderabad, Sept 18 (UNI) The National Stock Exchange (NSE) IPO is receiving a strong response from investors and is expected to be fully subscribed by the end of day, NSE Chief Business Development Officer (CBDO) Sriram Krishnan said on Friday.

see more..

Centre raises bulk sugar stock limit to 30 days to ensure adequate supplies

18 Sep 2026 | 6:21 PM

New Delhi, Sep 18 (UNI) The government has relaxed sugar stockholding norms for bulk users ahead of the festive season, allowing them to maintain inventory for up to 30 days of consumption. However, the additional stock beyond the existing 15-day ceiling will have to come exclusively from eligible imports under the Advance Authorisation Scheme (AAS) or Tariff Rate Quota (TRQ).

see more..